152 results on '"Zhang, Q."'
Search Results
2. CO14 Patient-Reported Outcomes (PROS) With Ramucirumab Versus Placebo in Chinese Patients With Hepatocellular Carcinoma (HCC) and Elevated Alpha-Fetoprotein From the Randomized Phase 3 Reach-2 Study
3. RWD104 Delayed Diagnosis Amongst gMG Patients: Results From a European Real-World Study
4. RWD137 Changing Priorities Among Physician Reported Reasons for Choice of Pharmacological gMG Treatments Across 5 European Countries
5. EE276 Patient Characteristics and Healthcare Resource Utilization in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: A Nationwide Population-Based Study in Sweden
6. PCR173 Health State Utilities Associated With X-Linked Retinitis Pigmentosa in the United States
7. MSR79 Evaluation of Real-World Response Rate in Clinical Trial-Aligned Cohorts of Patients With Lung, Colon, and Breast Cancer Using Machine Learning
8. EE363 Economic Value of Early Genetic Testing in Inherited Retinal Dystrophy Diagnosis
9. PDG10 Cost-Effectiveness Analysis of Gnrh Analogue ALONE Versus Combined Growth Hormone for Girls with Central Precocious Puberty
10. PCN187 Building Cancer Knowledge Graph for Clinical Decision Support Applications
11. PMH2 Patient Profiles and Hospital Re-encounters of Patients with a Hospital Emergency Department Visit or Inpatient Admission for Major Depressive Disorder
12. SA51 Severity Diagnosis and Neuropsychological Test Result from Clinical Notes Among Veterans with Alzheimer's Disease
13. SA33 Healthcare Utilization Among Veterans with Alzheimer's Disease Identified from Clinical Notes
14. RWD158 Development of a Derived Induction Failure and Relapse (DIFR) Variable for Acute Myeloid Leukemia (AML) Using Real-World (RW) Data from an Electronic Health Record (EHR)-Derived Database
15. HPR70 Therapeutic Preference for Alzheimer’S Disease Treatments: A Discrete Choice Experiment (DCE) with Caregivers and Neurologists
16. EE403 Direct and Indirect Costs Among Employed Patients with Myasthenia Gravis in Sweden
17. PCN345 Understanding the IMPACT of Assessment Frequency on the Study of Adverse Effects (AES) Using Oncology Electronic Health Records (EHRS)
18. PND108 Understanding the Evolution of Patient Burden across the Severity Stages of Alzheimer's Disease Using Online Social MEDIA
19. PND1 USE OF CLINICAL GLOBAL IMPRESSIONS-SEVERITY (CGI-S) TO ASSESS RESPONSE TO ANTIDEPRESSANT TREATMENT IN PATIENTS WITH TREATMENT-RESISTANT DEPRESSION
20. PIN21 ESTABLISH A PHARMACEUTICAL CARE MODE FOR THERAPEUTIC DRUG MONITORING OF VANCOMYCIN AND EVALUATE ITS EFFECTIVENESS AND ECONOMICS
21. PMH23 A RETROSPECTIVE CHART REVIEW STUDY TO QUANTIFY THE MONTHLY MEDICAL RESOURCE USE AND COSTS OF TREATING PATIENTS WITH TREATMENT RESISTANT DEPRESSION IN THE UNITED KINGDOM
22. PMH23 BUDGET IMPACT ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES
23. PCV62 ASSESSING THE RISK FACTORS OF HEART FAILURE AMONG PATIENTS IN THE DEPARTMENT OF DEFENSE POPULATION
24. PMH19 COST-EFFECTIVENESS ANALYSIS OF ESKETAMINE IN TREATMENT-RESISTANT DEPRESSION IN THE UNITED STATES
25. PSY40 - ALL-CAUSE MORTALITY INCREASED WITH NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE IN US MEDICARE
26. PSY30 - INCIDENCE AND PREVALENCE OF NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE IN US MEDICARE, 2008-2015
27. Identify The Temporal Medication Pattern In The Hypertensive Patients Using Sequential Pattern Mining and Relate The Patterns To The Outcome and Cost
28. Association of Treatment Resistant Depression with Healthcare Resource Utilization and Physician Satisfaction with Disease Management
29. Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases from Advanced Breast Cancer in Chinese Patients
30. The Economic Burden Among Patients with Treatment Resistant Depression in US Claims Data
31. Examining Health Care Utilization and Costs Among Atherosclerosis Patients in the US Veteran Health Administration Population
32. Healthcare Insurance Spending At Year 2 Between Treatment Groups Following Diagnosis Of Nontuberculous Mycobacterial Lung Disease In The US
33. Risk Factors And Diagnosis Of Nontuberculous Mycobacterial Lung Disease (NTMLD) In Incident Cohorts Of Bronchiectasis (BE) And Chronic Obstructive Pulmonary Disease (COPD) In A National US Managed Care Insurance Plan
34. Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
35. Health Care Utilization and Economic Burden of Pancreatic Cancer in The Us Medicare Population
36. PCV67 - Identify The Temporal Medication Pattern In The Hypertensive Patients Using Sequential Pattern Mining and Relate The Patterns To The Outcome and Cost
37. Evaluating the Economic Burden and Health Care Utilization of Coronary Artery Disease in the Us Medi-Cal Population
38. Finding Potential Predictors of Alzheimer’s Disease Using Medicare Claims Data
39. COMPARING HEALTH CARE RESOURCE UTILIZATION AND COSTS AMONG OBESE PATIENTS IN THE US MEDICAID POPULATION
40. Assessing The Economic Burden And Health Care Utilization Of Attention Deficit/Hyperactivity Disorder Among Medicaid Patients In The United States
41. Evaluating Asthma-Related Expenses And Health Care Resource Utilization Among Children In The United States Medicaid Population
42. PMH51 - Association of Treatment Resistant Depression with Healthcare Resource Utilization and Physician Satisfaction with Disease Management
43. PMH22 - The Economic Burden Among Patients with Treatment Resistant Depression in US Claims Data
44. PCN123 - Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases from Advanced Breast Cancer in Chinese Patients
45. PCV157 - Examining Health Care Utilization and Costs Among Atherosclerosis Patients in the US Veteran Health Administration Population
46. PSY106 - Risk Factors And Diagnosis Of Nontuberculous Mycobacterial Lung Disease (NTMLD) In Incident Cohorts Of Bronchiectasis (BE) And Chronic Obstructive Pulmonary Disease (COPD) In A National US Managed Care Insurance Plan
47. PSY55 - Healthcare Insurance Spending At Year 2 Between Treatment Groups Following Diagnosis Of Nontuberculous Mycobacterial Lung Disease In The US
48. Examination of Hospital-acquired Infective Endocarditis Using Medicare Claims data
49. Effect of Vaccination Age on Cost-Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer in China
50. The Application Of Natural Language Processing (Nlp) Technology To Enrich Electronic Medical Records (Emrs) For Outcomes Research In Oncology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.